Literature DB >> 34390014

Systematic review: radiomics for the diagnosis and prognosis of hepatocellular carcinoma.

Emily Harding-Theobald1, Jeremy Louissaint1, Bharat Maraj1, Edward Cuaresma1, Whitney Townsend2, Mishal Mendiratta-Lala3, Amit G Singal4, Grace L Su1, Anna S Lok1, Neehar D Parikh1.   

Abstract

BACKGROUND: Advances in imaging technology have the potential to transform the early diagnosis and treatment of hepatocellular carcinoma (HCC) through quantitative image analysis. Computational "radiomic" techniques extract biomarker information from images which can be used to improve diagnosis and predict tumour biology. AIMS: To perform a systematic review on radiomic features in HCC diagnosis and prognosis, with a focus on reporting metrics and methodologic standardisation.
METHODS: We performed a systematic review of all full-text articles published from inception through December 1, 2019. Standardised data extraction and quality assessment metrics were applied to all studies.
RESULTS: A total of 54 studies were included for analysis. Radiomic features demonstrated good discriminatory performance to differentiate HCC from other solid lesions (c-statistics 0.66-0.95), and to predict microvascular invasion (c-statistic 0.76-0.92), early recurrence after hepatectomy (c-statistics 0.71-0.86), and prognosis after locoregional or systemic therapies (c-statistics 0.74-0.81). Common stratifying features for diagnostic and prognostic radiomic tools included analyses of imaging skewness, analysis of the peritumoural region, and feature extraction from the arterial imaging phase. The overall quality of the included studies was low, with common deficiencies in both internal and external validation, standardised imaging segmentation, and lack of comparison to a gold standard.
CONCLUSIONS: Quantitative image analysis demonstrates promise as a non-invasive biomarker to improve HCC diagnosis and management. However, standardisation of protocols and outcome measurement, sharing of algorithms and analytic methods, and external validation are necessary prior to widespread application of radiomics to HCC diagnosis and prognosis in clinical practice.
© 2021 John Wiley & Sons Ltd.

Entities:  

Keywords:  HCC; MRI; biomarker; early detection; prognosis; radiogenomics

Mesh:

Year:  2021        PMID: 34390014      PMCID: PMC8435007          DOI: 10.1111/apt.16563

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   9.524


  92 in total

1.  Preoperative prediction of microvascular invasion in hepatocellular cancer: a radiomics model using Gd-EOB-DTPA-enhanced MRI.

Authors:  Shi-Ting Feng; Yingmei Jia; Bing Liao; Bingsheng Huang; Qian Zhou; Xin Li; Kaikai Wei; Lili Chen; Bin Li; Wei Wang; Shuling Chen; Xiaofang He; Haibo Wang; Sui Peng; Ze-Bin Chen; Mimi Tang; Zhihang Chen; Yang Hou; Zhenwei Peng; Ming Kuang
Journal:  Eur Radiol       Date:  2019-01-28       Impact factor: 5.315

2.  A Comparison of Staging Systems for Hepatocellular Carcinoma in a Multicenter US Cohort.

Authors:  Neehar D Parikh; Steve Scaglione; Yumeng Li; Corey Powell; Olutola A Yerokun; Pauline Devlin; Shaham Mumtaz; Sahil Mittal; Amit G Singal
Journal:  Clin Gastroenterol Hepatol       Date:  2017-10-05       Impact factor: 11.382

3.  Magnetic resonance texture analysis for the identification of cytokeratin 19-positive hepatocellular carcinoma.

Authors:  He-Qing Wang; Chun Yang; Meng-Su Zeng; Sheng-Xiang Rao; Yuan Ji; Xin Weng; Ji-Yong Wang; Ruo-Fan Sheng
Journal:  Eur J Radiol       Date:  2019-06-18       Impact factor: 3.528

4.  Radiomics Signature: A Potential Biomarker for the Prediction of Disease-Free Survival in Early-Stage (I or II) Non-Small Cell Lung Cancer.

Authors:  Yanqi Huang; Zaiyi Liu; Lan He; Xin Chen; Dan Pan; Zelan Ma; Cuishan Liang; Jie Tian; Changhong Liang
Journal:  Radiology       Date:  2016-06-27       Impact factor: 11.105

5.  Accuracy of the Liver Imaging Reporting and Data System in Computed Tomography and Magnetic Resonance Image Analysis of Hepatocellular Carcinoma or Overall Malignancy-A Systematic Review.

Authors:  Christian B van der Pol; Christopher S Lim; Claude B Sirlin; Trevor A McGrath; Jean-Paul Salameh; Mustafa R Bashir; An Tang; Amit G Singal; Andreu F Costa; Kathryn Fowler; Matthew D F McInnes
Journal:  Gastroenterology       Date:  2018-11-13       Impact factor: 22.682

6.  Heterogeneity of non-cancerous liver parenchyma on gadoxetic acid-enhanced MRI: an imaging biomarker for hepatocellular carcinoma development in chronic liver disease.

Authors:  Y Asayama; A Nishie; K Ishigami; Y Ushijima; Y Takayama; D Okamoto; N Fujita; K Morita; M Obara; H Honda
Journal:  Clin Radiol       Date:  2016-03-02       Impact factor: 2.350

7.  Predicting Survival Using Pretreatment CT for Patients With Hepatocellular Carcinoma Treated With Transarterial Chemoembolization: Comparison of Models Using Radiomics.

Authors:  Jonghoon Kim; Seung Joon Choi; Seung-Hak Lee; Ho Yun Lee; Hyunjin Park
Journal:  AJR Am J Roentgenol       Date:  2018-09-21       Impact factor: 3.959

8.  Hepatocellular carcinoma: preoperative gadoxetic acid-enhanced MR imaging can predict early recurrence after curative resection using image features and texture analysis.

Authors:  Su Joa Ahn; Jung Hoon Kim; Sang Joon Park; Seung Tack Kim; Joon Koo Han
Journal:  Abdom Radiol (NY)       Date:  2019-02

9.  Repeatability of Multiparametric Prostate MRI Radiomics Features.

Authors:  Michael Schwier; Joost van Griethuysen; Mark G Vangel; Steve Pieper; Sharon Peled; Clare Tempany; Hugo J W L Aerts; Ron Kikinis; Fiona M Fennessy; Andriy Fedorov
Journal:  Sci Rep       Date:  2019-07-01       Impact factor: 4.379

10.  CT-based peritumoral radiomics signatures to predict early recurrence in hepatocellular carcinoma after curative tumor resection or ablation.

Authors:  Quan-Yuan Shan; Hang-Tong Hu; Shi-Ting Feng; Zhen-Peng Peng; Shu-Ling Chen; Qian Zhou; Xin Li; Xiao-Yan Xie; Ming-de Lu; Wei Wang; Ming Kuang
Journal:  Cancer Imaging       Date:  2019-02-27       Impact factor: 3.909

View more
  10 in total

1.  Association of Previous Gastric Bypass Surgery and Patient Outcomes in Alcohol-Associated Cirrhosis Hospitalizations.

Authors:  Pradeep Yarra; Winston Dunn; Zobair Younossi; Yong-Fang Kuo; Ashwani K Singal
Journal:  Dig Dis Sci       Date:  2022-07-04       Impact factor: 3.199

2.  A Multiparametric Method Based on Clinical and CT-Based Radiomics to Predict the Expression of p53 and VEGF in Patients With Spinal Giant Cell Tumor of Bone.

Authors:  Qizheng Wang; Yang Zhang; Enlong Zhang; Xiaoying Xing; Yongye Chen; Ke Nie; Huishu Yuan; Min-Ying Su; Ning Lang
Journal:  Front Oncol       Date:  2022-06-21       Impact factor: 5.738

Review 3.  Stereotactic body radiation therapy for hepatocellular carcinoma: From infancy to ongoing maturity.

Authors:  Shirley Lewis; Laura Dawson; Aisling Barry; Teodor Stanescu; Issa Mohamad; Ali Hosni
Journal:  JHEP Rep       Date:  2022-05-14

4.  Correlation of LI-RADS 3 or 4 Observations with Histopathologic Diagnosis in Patients with Cirrhosis.

Authors:  Colin Dunn; Bo Lin; Nicole E Rich; Madhukar S Patel; Purva Gopal; Amit G Singal
Journal:  Clin Gastroenterol Hepatol       Date:  2022-03-17       Impact factor: 13.576

5.  MRI-Based Radiomic Features Help Identify Lesions and Predict Histopathological Grade of Hepatocellular Carcinoma.

Authors:  Valentina Brancato; Nunzia Garbino; Marco Salvatore; Carlo Cavaliere
Journal:  Diagnostics (Basel)       Date:  2022-04-26

6.  DETECT: Development of Technologies for Early HCC Detection.

Authors:  Jihane N Benhammou; Nicole E Rich; George Cholankeril; Peng Zhang; Weihua Zeng; Shuyun Rao; Nabihah Tayob
Journal:  Gastroenterology       Date:  2022-03-23       Impact factor: 33.883

7.  Classification of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma Based on Radiomic Analysis.

Authors:  Xiaoliang Xu; Yingfan Mao; Yanqiu Tang; Yang Liu; Cailin Xue; Qi Yue; Qiaoyu Liu; Jincheng Wang; Yin Yin
Journal:  Comput Math Methods Med       Date:  2022-02-21       Impact factor: 2.238

8.  Noninvasive Imaging Evaluation Based on Computed Tomography of the Efficacy of Initial Transarterial Chemoembolization to Predict Outcome in Patients with Hepatocellular Carcinoma.

Authors:  Yanmei Dai; Huijie Jiang; Shi-Ting Feng; Yuwei Xia; Jinping Li; Sheng Zhao; Dandan Wang; Xu Zeng; Yusi Chen; Yanjie Xin; Dongmin Liu
Journal:  J Hepatocell Carcinoma       Date:  2022-04-05

9.  Radiomics of Contrast-Enhanced Computed Tomography: A Potential Biomarker for Pretreatment Prediction of the Response to Bacillus Calmette-Guerin Immunotherapy in Non-Muscle-Invasive Bladder Cancer.

Authors:  Lei Ye; Yuntian Chen; Hui Xu; Zhaoxiang Wang; Haixia Li; Jin Qi; Jing Wang; Jin Yao; Jiaming Liu; Bin Song
Journal:  Front Cell Dev Biol       Date:  2022-02-25

10.  miR-3682-3p directly targets FOXO3 and stimulates tumor stemness in hepatocellular carcinoma via a positive feedback loop involving FOXO3/PI3K/AKT/c-Myc.

Authors:  Qian Chen; Si-Bo Yang; Ye-Wei Zhang; Si-Yuan Han; Lei Jia; Bo Li; Yi Zhang; Shi Zuo
Journal:  World J Stem Cells       Date:  2022-07-26       Impact factor: 5.247

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.